China is the world's largest production base of vitamins, with vitamin C and vitamin E as its most important products, wherein vitamin C and related products account for more than 60% of its total output and vitamin E takes up about 30%. Since 2009, influenced by the sluggish external demand and declining prices, China's output of vitamin products has been declining sharply. In 2013, the output of various types of vitamin products in China was about 201,000 tons, down 7.4% YoY.
China is also the world's largest export base of vitamins, mainly vitamin C, vitamin E and pantothenic calcium. In 2013, China's export volume of vitamin C and vitamin E accounted for 55.0% and 23.7% of total export volume over the same period. In addition, the proportions of D or DL-pantothenic acid (i.e. vitamin B3 or B5) have increased to 5.7%.
Chinese vitamin producers fall into two types: large integrated pharmaceutical enterprises and professional vitamin producers. In 2009-2013, large integrated pharmaceutical enterprises such as North China Pharmaceutical Co.,Ltd and Northeast Pharmaceutical Group Co.,Ltd mostly had heavy burden historically and encountered operating difficulties and development obstacles, thus their ratio of R & D investment in total revenue was less than 3%; while professional vitamin producers like NHU, Kingdomway, and Brother Enterprises Holding kept higher gross margins of their products, with R & D investment generally accounting for more than 4% of revenue.
In recent years, the global and Chinese vitamin market has been exhibiting a monopolistic competition pattern. CSPC Pharmaceutical Group, North China Pharmaceutical, Northeast Pharmaceutical, Aland (Jiangsu) Nutraceutical, Shandong Luwei Pharmaceutical and other Chinese companies with production capacity of more than 15,000 tons, are the major suppliers in the global VC market. Zhejiang Medicine, NHU, and PKU Healthcare together shared about 50% of the global total capacity of VE. NHU, Zhejiang Medicine and Kingdomway three companies together accounted for 40%-50% of the global total capacity of VA.
Since the vitamin industry has high technical barriers, the existing major producers have already formed their own competitive advantages and the cost of quitting is high. So it is estimated that in 2014-2017, the monopolistic competition pattern in China vitamin industry will persist.
"China Vitamin Industry Report, 2014-2017" provided by ResearchInChina covers the following:
China vitamin market supply and demand, import and export, competition pattern and development projections; Development status, competition pattern, import and export, market prices of VC, VA, VB, VE products in China; Operation, vitamin business and development prospects of 16 global and Chinese vitamin companies.
Our reports have been used by over 10K customers, including:
2021 Vitamins and Herbal Dietary Supplement Market - Size, Share, COVID Impact Analysis and Forecast to 2027 2021 Vitamins and Herbal Dietary Supplement Market - Size, Share, COVID Impact Analysis and Forecast to 2027 – is comprehensive research with in-depth data and contemporary analysis of Vitamins and Herbal Dietary...
88 pages •
By Euromonitor International
• Nov 2020
Consumer health is expected to see much higher current value growth in 2020 than was seen the previous year. One of the factors dictating growth in this year is expected to be COVID-19. As news about the virus emerged in the country, consumers began panic-buying at the beginning of March, stockpiling certain consumer health products, such...
123 pages •
By Euromonitor International
• Oct 2020
Consumer health in the UK was positively impacted by the emergence of COVID-19 in Q2 2020 due to notable stockpiling behaviour, a focus on preventive health and consumers adjusting to the new normal. The pandemic and the subsequent lockdown measures introduced by the government in an attempt to halt the spread of the virus resulted in a shift...
118 pages •
By Euromonitor International
• Oct 2020
The Netherlands was hit by COVID-19 in 2020 and the country went into long periods of partial lockdown. In May
Consumer Health in Netherlands report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving...
90 pages •
By Euromonitor International
• Nov 2020
Consumer health is expected to see slightly higher current value growth in 2020 than was seen in 2019, with COVID-19 expected to be one of the main factors dictating growth in Uruguay. While the COVID-19 outbreak in Uruguay had little impact in terms of infections and deaths due to the country’s good healthcare system, locals’ concern about...
94 pages •
By Euromonitor International
• Nov 2020
With Kenyans mired in the COVID-19 pandemic, it is perhaps not surprising that value sales of consumer health products are set to rise in 2020 at a rate higher than those recorded during the review period. Broadly, a pandemic-inspired heightened focus on maintaining/improving health is driving greater interest in over the counter (OTC) health...
91 pages •
By Euromonitor International
• Nov 2020
The main developments in consumer health in Costa Rica in 2020 as a result of COVID-19 are related to the sudden spike in the sales of vitamins and dietary supplements, particularly those associated to immunity responses. For example, echinacea has gained significant awareness amongst local consumers in 2020. COVID-19 resulted in shortages...
193 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Amaranth Oil Market to Reach $1.4 Billion by 2027
- Amid the COVID-19 crisis, the global market for Amaranth Oil estimated at US$682.2 Million in the year 2020, is projected to reach a revised size of US$1.4 Billion by 2027, growing at a CAGR of 10.5% over the analysis period 2020-2027. Cosmetic...
293 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Mixed Tocopherols Market to Reach $5.7 Billion by 2027
- Amid the COVID-19 crisis, the global market for Mixed Tocopherols estimated at US$4.4 Billion in the year 2020, is projected to reach a revised size of US$5.7 Billion by 2027, growing at a CAGR of 3.8% over the analysis period 2020-2027. Soybean...
165 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Coenzyme Q10 Market to Reach $1.1 Billion by 2027
- Amid the COVID-19 crisis, the global market for Coenzyme Q10 estimated at US$602.8 Million in the year 2020, is projected to reach a revised size of US$1.1 Billion by 2027, growing at a CAGR of 8.6% over the analysis period 2020-2027. Dietary Supplements,...
Cosmetics
Pharmaceutical
Dietary Supplement
World
China
United States
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.